According to Xie et al., a diagnostic panel for NSCLC (non-small-cell lung carcinoma) has higher specificity (79.2%) and sensitivity (77.1%) than any single molecular marker, such as CEA and lncRNA ANRIL (Xie et al., 2018). This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.